The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Acromegaly
Abstract
Pituitary tumors account for about 15% of primary intracranial neoplasms. Proliferation of pituitary cells, which secrete hormones, may result in a spectrum of endocrine symptoms. Tumors that originate from pituitary somatotroph cells lead to aberrant secretion of growth hormone and the distinctive features of acromegaly. This review discusses advances in the understanding and treatment of acromegaly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Jane, J. A. (2005) · Neurosurgical FOCUS · doi:10.3171/foc.2005.19.5.5 · Cited by 113
RetractedGhrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Landis, C. A., Masters, S. B., Spada, A., Pace, A. M., Bourne, H. R., & Vallar, L. (1989) · Nature · doi:10.1038/340692a0 · Cited by 1,441
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0022 · Cited by 1,309
Lamberts, S. W. J., van der Lely, A.-J., de Herder, W. W., & Hofland, L. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340408 · Cited by 1,001
Criteria for Cure of Acromegaly: A Consensus Statement
Giustina, A. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.526 · Cited by 987
Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase
Argetsinger, L. S., Campbell, G. S., Yang, X., Witthuhn, B. A., Silvennoinen, O., Ihle, J. N., & Carter-Su, C. (1993) · Cell · doi:10.1016/0092-8674(93)90415-m · Cited by 974
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
Trainer, P. J., Drake, W. M., Katznelson, L., Freda, P. U., Herman-Bonert, V., van der Lely, A. J., Dimaraki, E. V., Stewart, P. M., Friend, K. E., Vance, M. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004203421604 · Cited by 879
Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study1
Orme, S. M., McNally, R. J. Q., Cartwright, R. A., & Belchetz, P. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5007 · Cited by 805
Factors Influencing Mortality in Acromegaly
Holdaway, I. M., Rajasoorya, R. C., & Gamble, G. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031199 · Cited by 651
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
van der Lely, A. J., Hutson, R. K., Trainer, P. J., Besser, G. M., Barkan, A. L., Katznelson, L., Klibanski, A., Herman-Bonert, V., Melmed, S., Vance, M. L., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06844-1 · Cited by 645
Self-citationLong-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly1
Swearingen, B., Barker, F. G., Katznelson, L., Biller, B. M. K., Grinspoon, S., Klibanski, A., Moayeri, N., Black, P. M., & Zervas, N. T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5222 · Cited by 586
Determinants of clinical outcome and survival in acromegaly
Rajasoorya, C., Holdaway, I. M., Wrightson, P., Scott, D. J., & Ibbertson, H. K. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03789.x · Cited by 565
Opportunities in somatostatin research: biological, chemical and therapeutic aspects
Weckbecker, G., Lewis, I., Albert, R., Schmid, H. A., Hoyer, D., & Bruns, C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1255 · Cited by 559
Ho, K. Y., Veldhuis, J. D., Johnson, M. L., Furlanetto, R., Evans, W. S., Alberti, K. G., & Thorner, M. O. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113450 · Cited by 503
Mechanisms for pituitary tumorigenesis: the plastic pituitary
Melmed, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320401 · Cited by 456
Self-citationMelmed, S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004053221405 · Cited by 438
Self-citationLong-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly
Swearingen, B. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.10.3419 · Cited by 400
Holdaway, I. M., & Rajasoorya, C. (1999) · Pituitary · doi:10.1023/a:1009965803750 · Cited by 394
Thorner, M. O., Perryman, R. L., Cronin, M. J., Rogol, A. D., Draznin, M., Johanson, A., Vale, W., Horvath, E., & Kovacs, K. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110708 · Cited by 393
Minniti, G., Traish, D., Ashley, S., Gonsalves, A., & Brada, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1152 · Cited by 377
Model for growth hormone receptor activation based on subunit rotation within a receptor dimer
Brown, R. J., Adams, J. J., Pelekanos, R. A., Wan, Y., McKinstry, W. J., Palethorpe, K., Seeber, R. M., Monks, T. A., Eidne, K. A., Parker, M. W., et al. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb977 · Cited by 368
Brabant, G., von zur Mühlen, A., Wüster, C., Ranke, M. B., Kratzsch, J., Kiess, W., Ketelslegers, J.-M., Wilhelmsen, L., Hulthén, L., Saller, B., et al. (2003) · Hormone Research in Paediatrics · doi:10.1159/000071871 · Cited by 360
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
Kopchick, J. J., Parkinson, C., Stevens, E. C., & Trainer, P. J. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0022 · Cited by 352
Ayuk, J., Clayton, R. N., Holder, G., Sheppard, M. C., Stewart, P. M., & Bates, A. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031584 · Cited by 343
Guidelines for Acromegaly Management
Melmed, S., Casanueva, F. F., Cavagnini, F., Chanson, P., Frohman, L., Grossman, A., Ho, K., Kleinberg, D., Lamberts, S., Laws, E., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-011841 · Cited by 343
Self-citationKreutzer, J., Vance, M. L., Lopes, M. B. S., & Laws, E. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4072 · Cited by 341
Heaney, A. P., Horwitz, G. A., Wang, Z., Singson, R., & Melmed, S. (1999) · Nature Medicine · doi:10.1038/15275 · Cited by 337
Self-citationA Nationwide Survey of Mortality in Acromegaly
Kauppinen-Mäkelin, R., Sane, T., Reunanen, A., Välimäki, M. J., Niskanen, L., Markkanen, H., Löyttyniemi, E., Ebeling, T., Jaatinen, P., Laine, H., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1381 · Cited by 269
Shimon, I., Yan, X., Taylor, J. E., Weiss, M. H., Culler, M. D., & Melmed, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119779 · Cited by 260
Self-citationSOCS2 negatively regulates growth hormone action in vitro and in vivo
Greenhalgh, C. J., Rico-Bautista, E., Lorentzon, M., Thaus, A. L., Morgan, P. O., Willson, T. A., Zervoudakis, P., Metcalf, D., Street, I., Nicola, N. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522710 · Cited by 258
Tannenbaum, G. S., Epelbaum, J., & Bowers, C. Y. (2003) · Endocrinology · doi:10.1210/en.2002-220852 · Cited by 247
Acromegaly with Apparently Normal GH Secretion: Implications for Diagnosis and Follow-Up
Dimaraki, E. V., Jaffe, C. A., DeMott-Friberg, R., Chandler, W. F., & Barkan, A. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3537 · Cited by 235
Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly
Feenstra, J., de Herder, W., ten Have, S., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)63011-5 · Cited by 233
Cozzi, R., Montini, M., Attanasio, R., Albizzi, M., Lasio, G., Lodrini, S., Doneda, P., Cortesi, L., & Pagani, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2347 · Cited by 228
Castinetti, F., Taieb, D., Kuhn, J.-M., Chanson, P., Tamura, M., Jaquet, P., Conte-Devolx, B., Régis, J., Dufour, H., & Brue, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0311 · Cited by 225
Cardiovascular Function in Acromegaly
Clayton, R. N. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0009 · Cited by 223
Jenkins, P. J., Bates, P., Carson, M. N., Stewart, P. M., & Wass, J. A. H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1616 · Cited by 221
Leung, K. C., Doyle, N., Ballesteros, M., Sjogren, K., Watts, C. K. W., Low, T. H., Leong, G. M., Ross, R. J. M., & Ho, K. K. Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337600100 · Cited by 218
Barrande, G., Pittino-Lungo, M., Coste, J., Ponvert, D., BERTAGNA, X. Y., LUTON, J. P., & Bertherat, J. Y. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3779 · Cited by 216
A Critical Analysis of Pituitary Tumor Shrinkage during Primary Medical Therapy in Acromegaly
Melmed, S., Sternberg, R., Cook, D., Klibanski, A., Chanson, P., Bonert, V., Vance, M. L., Rhew, D., Kleinberg, D., & Barkan, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2466 · Cited by 215
Self-citationBiermasz, N. R., Pereira, A. M., Smit, J. W. A., Romijn, J. A., & Roelfsema, F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2297 · Cited by 209
Pituitary Tumor Registry: A Novel Clinical Resource
Drange, M. R., Fram, N. R., Herman-Bonert, V. S., & Melmed, S. K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6309 · Cited by 199
Self-citationCLINICAL PERSPECTIVE: Acromegaly and Cancer: Not a Problem?
Melmed, S. K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.7.2929 · Cited by 196
Self-citationBiermasz, N. R., Dekker, F. W., Pereira, A. M., van Thiel, S. W., Schutte, P. J., van Dulken, H., Romijn, J. A., & Roelfsema, F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032041 · Cited by 193
Colao, A., Attanasio, R., Pivonello, R., Cappabianca, P., Cavallo, L. M., Lasio, G., Lodrini, A., Lombardi, G., & Cozzi, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1208 · Cited by 191
What is the role of circulating IGF-I?
Roith, D. L., Scavo, L., & Butler, A. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00349-0 · Cited by 189
CLINICAL PERSPECTIVE: Acromegaly and Cancer: A Problem
Jenkins, P. J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.7.2935 · Cited by 189
Bonadonna, S., Mazziotti, G., Nuzzo, M., Bianchi, A., Fusco, A., De Marinis, L., & Giustina, A. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050603 · Cited by 188
Barkan, A. L., Burman, P., Clemmons, D. R., Drake, W. M., Gagel, R. F., Harris, P. E., Trainer, P. J., van der Lely, A. J., & Vance, M. L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0331 · Cited by 187
Outcome of surgery for acromegaly--the experience of a dedicated pituitary surgeon
Gittoes, N. J. L. (1999) · QJM · doi:10.1093/qjmed/92.12.741 · Cited by 176
Cotreatment of Acromegaly with a Somatostatin Analog and a Growth Hormone Receptor Antagonist
Jørgensen, J. O. L., Feldt-Rasmussen, U., Frystyk, J., Chen, J.-W., Kristensen, L. Ø., Hagen, C., & Ørskov, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0531 · Cited by 173
Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study
Orme, S. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2730 · Cited by 173
Increased Prevalence of Regurgitant Valvular Heart Disease in Acromegaly
Pereira, A. M., van Thiel, S. W., Lindner, J. R., Roelfsema, F., van der Wall, E. E., Morreau, H., Smit, J. W. A., Romijn, J. A., & Bax, J. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030849 · Cited by 170
Transsphenoidal Surgery for Acromegaly: Endocrinological Follow-up of 98 Patients
Shimon, I., Cohen, Z. R., Ram, Z., & Hadani, M. (2001) · Neurosurgery · doi:10.1097/00006123-200106000-00008 · Cited by 170
Central and peripheral actions of somatostatin on the growth hormone–IGF-I axis
Murray, R. D., Kim, K., Ren, S.-G., Chelly, M. R., Umehara, Y., & Melmed, S. K. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19933 · Cited by 162
Self-citationFedele, M., Pentimalli, F., Baldassarre, G., Battista, S., Klein–Szanto, A. J., Kenyon, L. C., Visone, R., Martino, I. D., Ciarmiello, A., Arra, C., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208501 · Cited by 157
van der Hoek, J., de Herder, W. W., Feelders, R. A., van der Lely, A. J., Uitterlinden, P., Boerlin, V., Bruns, C., Poon, K. W., Lewis, I., Weckbecker, G., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031052 · Cited by 144
Effect of Octreotide, a Somatostatin Analog, on Sleep Apnea in Patients with Acromegaly
Grunstein, R. R., Ho, K. K. Y., & Sullivan, C. E. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-7-199410010-00002 · Cited by 134
Increased epithelial cell proliferation in the colon of patients with acromegaly.
Cats, A., Dullaart, R. P. F., Kleibeuker, J. H., Kuipers, F., Sluiter, W. J., Hardonk, M., & de Vries, E. G. E. (1996) · PubMed · Cited by 125
Powell, J. S., Wardlaw, S. L., Post, K. D., & Freda, P. U. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.2068 · Cited by 114
Puder, J. J., Nilavar, S., Post, K. D., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2009 · Cited by 112
Pituitary Carcinoma: A Clinicopathological Review
Scheithauer, B. W., Yapıcıer, Ö., Kovács, K., Young, W. F., & Lloyd, R. V. (2005) · Neurosurgery · doi:10.1227/01.neu.0000157926.72826.db · Cited by 109
Primary medical therapy for acromegaly
Sheppard, M. C. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01734.x · Cited by 109
Pituitary Tumor Registry: A Novel Clinical Resource
Drange, M. R. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.168 · Cited by 108
Giustina, A., Boni, E., Romanelli, G., Grossi, V., & Giustina, G. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80721-8 · Cited by 94
Costa, A. C. F., Rossi, A., Martinelli, C. E., Machado, H. R., & Moreira, A. C. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3142 · Cited by 93
Ronchi, C. L., Varca, V., Beck‐Peccoz, P., Orsi, E., Donadio, F., Baccarelli, A., Giavoli, C., Ferrante, E., Lania, A. G., Spada, A., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1704 · Cited by 90
Milani, D., Carmichael, J. D., Welkowitz, J., Ferris, S. H., Reitz, R. E., Danoff, A., & Kleinberg, D. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032150 · Cited by 87
Molecular defects in the pathogenesis of pituitary tumours
Levy, A., & Lightman, S. L. (2003) · Frontiers in Neuroendocrinology · doi:10.1016/s0091-3022(03)00012-8 · Cited by 86
Ren, S.-G., Kim, S., Taylor, J., Dong, J., Moreau, J.-P., Culler, M. D., & Melmed, S. K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030302 · Cited by 85
Self-citationPeacey, S. R., Toogood, A. A., Veldhuis, J. D., Thorner, M. O., & Shalet, S. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7154 · Cited by 83
Rheumatologic and Skeletal Changes in Acromegaly
Lieberman, S. A., Björkengren, A. G., & Hoffman, A. R. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30205-6 · Cited by 82
Biering, H., Saller, B., Bauditz, J., Pirlich, M., Rudolph, B., Johne, A., Buchfelder, M., Mann, K., Droste, M., Schreiber, I., et al. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02079 · Cited by 81
Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly
Colao, A., Cannavò, S., Marzullo, P., Pivonello, R., Squadrito, S., Vallone, G., Almoto, B., Bichisao, E., Trimarchi, F., & Lombardi, G. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480031 · Cited by 63
Genetics and Proteomics of Pituitary Tumors
Asa, S. L., & Ezzat, S. (2005) · Endocrine · doi:10.1385/endo:28:1:043 · Cited by 43
Pituitary Carcinoma: A Clinicopathological Review
Scheithauer, B. W. (2006) · Neurosurgery · doi:10.1227/01.neu.0000214117.87793.6f · Cited by 39
Zhang, X. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.3.1262 · Cited by 35
How Robust Are Laboratory Measures of Growth Hormone Status?
Strasburger, C. J., & Bidlingmaier, M. (2005) · Hormone Research in Paediatrics · doi:10.1159/000087745 · Cited by 31
Cited by
Acromegaly: An Endocrine Society Clinical Practice Guideline
Katznelson, L., Laws, E. R., Melmed, S., Molitch, M. E., Murad, M. H., Utz, A., & Wass, J. A. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2700 · Cited by 1,786
Self-citationDiagnosis and Treatment of Pituitary Adenomas: A Review
Molitch, M. E. (2017) · JAMA · doi:10.1001/jama.2016.19699 · Cited by 933
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Giustina, A., Mazziotti, G., & Canalis, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0036 · Cited by 914
A Consensus on Criteria for Cure of Acromegaly
Giustina, A., Chanson, P., Bronstein, M. D., Klibanski, A., Lamberts, S., Casanueva, F. F., Trainer, P., Ghigo, E., Ho, K., & Melmed, S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2670 · Cited by 783
Self-citationGuidelines for Acromegaly Management: An Update
Melmed, S., Colao, A., Barkan, A., Molitch, M., Grossman, A. B., Kleinberg, D., Clemmons, D., Chanson, P., Laws, E., Schlechte, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2421 · Cited by 764
Self-citation
Metadata
- Authors
- Melmed, S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-12-14
- Volume
- 355
- Issue
- 24
- Pages
- 2558-2573
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W123434114
- Cited by
- 1,160
- References
- 80
- FWCI
- 33.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.